gip/glp-1 agonist GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know GIP (Gastric Inhibitory Polypeptide) Assay

All analyses incorporated matching weights with robust standard error estimation

In recent years, GLP-1RAs have made significant advancements in the treatment of diabetes

Exenatide immediate-release (Byetta): Initiation involves a 5 mcg dose administered subcutaneously twice daily, which can be increased to 10 mcg twice daily after a month if required

Ozempic, a GLP-1 receptor agonist, mimics these effects to reduce hunger and promote weight loss

SGLT2i HR range from 0.83 [95% CI 0.571.27] to 0.95 [0.851.06]

Because of this, the primary concern during breastfeeding is nutritional intake rather than drug exposure through milk